The use of dual antiplatelet therapy for the first three-six months after transcatheter aortic valve implantation (TAVI) has beensuggested.[1,2] However, the ad
BACKGROUND M1 polarization of macrophages is an important pathological process in myocardial ischemia reperfusion injury,which is the major obstacle for the tre